Wrinkle fighter Botox has a new owner
AbbVie will soon own Botox , Dublin based Allergan’s prized medical aesthetics franchise, and along with its roughly $4 billion in sales, it will lay claim to a new $176 million plant at the site in Ireland where the blockbuster is exclusively produced. Botox turned in about $2.8 billion in sales in the first nine months of 2019 for both cosmetic and medical uses. Botox as a cosmetic product represents year-over-year increases of 6.7% and 10.7% in the US and elsewhere respectively. Evolus’s botox competitor Jeuveau is largely considered a much tougher rival for Botox to fend off compared with other existing challengers, such as Galderma’s Dysport and Merz’s Xeomin.
Subscribe to our free newsletter to read the latest news and articles before they are published.